A Phase 1b/2a, Multicentre, Open Label Study of the Pharmacokinetics, Safety and Efficacy of AMP945 in Combination with Nab-paclitaxel and Gemcitabine in Pancreatic Cancer Patients

  • Frentzas, Sophia (Primary Chief Investigator (PCI))
  • Harris, Marion (Chief Investigator (CI))
  • Lau, David (Chief Investigator (CI))

Project: Research

Project Details

Project Description


StatusActive
Effective start/end date31/05/22 → 30/05/27

Keywords

  • phase 1 study
  • Pharmacokinetics
  • pancreatic cancer
  • treatment efficacy
  • treatment safety
  • multicentre trial

Clinical Trial Phase

  • Phase I
  • Phase II